U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
135931135931Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 YearsCompletedNo Results AvailableAcute Myeloid LeukemiaDrug: Sunitinibhttps://ClinicalTrials.gov/show/NCT00783653
135932135932Dermacyd Femina (Lactic Acid) Pocket BR - Photo EvaluationCompletedNo Results AvailableHygieneDrug: Lactic Acidhttps://ClinicalTrials.gov/show/NCT00783640
135933135933Sickle Cell Disease and Endothelial Progenitor Cells (EPCs)CompletedNo Results AvailableSickle Cell AnemiaProcedure: Angiographyhttps://ClinicalTrials.gov/show/NCT00783627
135934135934Aspirin and Antiretroviral Therapy in HIV Infected PatientsTerminatedHas ResultsHIV InfectionDrug: Aspirin 325mg|Drug: Antiretroviral therapy (ART)https://ClinicalTrials.gov/show/NCT00783614
135935135935MK0524 Asthma POC Study (0524-008)(COMPLETED)CompletedNo Results AvailableAsthmaDrug: Comparator: MK0524 + placebo|Drug: Comparator: MK0524 + montelukast|Drug: Comparator: placebo + montelukast|Drug: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00783601
135936135936A Phase I Extension Trial of Repeated Infusions of ISF35CompletedNo Results AvailableChronic Lymphocytic LeukemiaBiological: ISF35https://ClinicalTrials.gov/show/NCT00783588
135937135937Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's DiseaseWithdrawnNo Results AvailableCrohn's Disease|Ulcerative Colitis|Inflammatory Bowel Diseasehttps://ClinicalTrials.gov/show/NCT00783575
135938135938Preventive Intervention in Nursery School TeachersCompletedNo Results AvailableLow Back Pain|Neck PainOther: Extension-oriented exercise program|Other: Informative Brochurehttps://ClinicalTrials.gov/show/NCT00783562
135939135939A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs.CompletedNo Results AvailableType 2 Diabetes MellitusDrug: an undetermined dose of GSK1292263|Drug: ascending dose of GSK1292263|Drug: ascending dose of GSK1292263|Drug: ascending dose of GSK1292263|Drug: ascending dose of GSK1292263https://ClinicalTrials.gov/show/NCT00783549
135940135940A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid ArthritisWithdrawnNo Results AvailableRheumatoid ArthritisDrug: Etanercept + Methotrexate|Drug: DMARDShttps://ClinicalTrials.gov/show/NCT00783536
135941135941Influence of MMP on Brain AVM HemorrhageCompletedNo Results AvailableArteriovenous Malformations|Cavernous Angiomas|Brain AneurysmsDrug: Doxycycline or Placebohttps://ClinicalTrials.gov/show/NCT00783523
135942135942Juvenile Idiopathic Arthritis (JIA) RegistryActive, not recruitingNo Results AvailableJuvenile Idiopathic Arthritis|JIABiological: adalimumab|Drug: Methotrexatehttps://ClinicalTrials.gov/show/NCT00783510
135943135943Evaluating the Relationship Between Stress, Ethnicity, and Blood PressureCompletedNo Results AvailableHypertensionhttps://ClinicalTrials.gov/show/NCT00783497
135944135944A Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Oral Doses Of PF-03716539 In Healthy Adult SubjectsCompletedNo Results AvailableHealthy VolunteersDrug: PF-03716539|Drug: PF-03716539|Drug: PF-03716539|Other: Placebo|Drug: PF-03716539|Drug: PF-03716539|Drug: PF-03716539|Other: Placebo|Drug: Midazolam|Drug: Midazolam + PF-03716539 (100 mg)|Drug: Midazolam + PF-03716539 (50 mg)|Drug: Darunavir|Drug: Darunavir + PF-03716539|Drug: Maraviroc|Drug: Maraviroc +PF-03716539|Drug: Maraviroc|Drug: Maraviroc +PF-03716539https://ClinicalTrials.gov/show/NCT00783484
135945135945Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)TerminatedNo Results AvailableAdvanced Non-Small Cell Lung CancerDrug: Erlotinib, Docetaxel|Drug: Docetaxel, Erlotinibhttps://ClinicalTrials.gov/show/NCT00783471
135946135946Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208)CompletedNo Results AvailableAllergic RhinitisDrug: Mometasone Furoate Nasal Spray|Drug: fluticasone nasal sprayhttps://ClinicalTrials.gov/show/NCT00783458
135947135947Evaluating the Effectiveness of a Community Exercise Program to Reduce the Risk of Metabolic Syndrome Among Black AmericansCompletedNo Results AvailableMetabolic SyndromeBehavioral: Community-Based Exercise Program (C-FIT)|Behavioral: Self-Help Exercise Program (HOME)https://ClinicalTrials.gov/show/NCT00783445
135948135948Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic RhinitisCompletedHas ResultsChronic Allergic Rhinitis|Nonallergic RhinitisDrug: Astepro Nasal Spray (0.1% azelastine hydrochloride)|Drug: Astelin Nasal Spray (0.1% azelastine hydrochloride)https://ClinicalTrials.gov/show/NCT00783432
135949135949Rate of Pelvic Inflammatory Disease at St. Michael's HospitalCompletedNo Results AvailablePelvic Inflammatory Diseasehttps://ClinicalTrials.gov/show/NCT00783419
135950135950Safety, Toleration and Efficacy of Single Inhaled Doses of PF-00610355 in Chronic Obstructive Pulmonary (COPD) Patients.CompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: PF-00610355|Drug: PF-00610355|Drug: PF-00610355|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00783406
135951135951SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745)CompletedNo Results AvailableAstrocytomaDrug: Temozolomidehttps://ClinicalTrials.gov/show/NCT00783393
135952135952Influenza Vaccination in Immunocompromized PatientsCompletedNo Results AvailableImmunosuppressionBiological: Virosomal influenza vaccine|Biological: Subunit influenza vaccinehttps://ClinicalTrials.gov/show/NCT00783380
135953135953Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell LymphomasCompletedNo Results AvailableFollicular Lymphoma|Marginal Zone B-Cell Lymphoma|MALT Lymphoma|Lymphoma of Mucosa-Associated Lymphoid Tissue|Lymphoma, Small Lymphocytic|Waldenstrom Macroglobulinemia|Mantle-Cell LymphomaDrug: lenalidomide-low dose dexamethasone plus rituximab|Drug: Lenalidomide + Rituximabhttps://ClinicalTrials.gov/show/NCT00783367
135954135954A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)CompletedNo Results AvailableUrticaria|Chronic Idiopathic UrticariaDrug: desloratadine|Drug: desloratadinehttps://ClinicalTrials.gov/show/NCT00783354
135955135955Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered IntravenouslyCompletedNo Results AvailableHealthy SubjectsDrug: GAP-134|Drug: placebohttps://ClinicalTrials.gov/show/NCT00783341
135956135956A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid TumorsCompletedNo Results AvailableNeoplasmsDrug: PF-00299804https://ClinicalTrials.gov/show/NCT00783328
135957135957Evaluating Weight Loss Programs for Obese People at Risk for Heart Disease (The POWER Study)Active, not recruitingNo Results AvailableObesityBehavioral: Call-Center Directed (CCD) Weight Loss Program|Behavioral: In-Person Directed (IPD) Weight Loss Program|Behavioral: Self-Directed Weight Loss Programhttps://ClinicalTrials.gov/show/NCT00783315
135958135958Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical CareCompletedHas ResultsCoronary Artery Disease (CAD)https://ClinicalTrials.gov/show/NCT00783302
135959135959A Phase 2a Study to Evaluate the Safety and Tolerability of MEDI-563 in Adults With AsthmaCompletedNo Results AvailableAsthmaBiological: MEDI-563|Other: Placebohttps://ClinicalTrials.gov/show/NCT00783289
135960135960An fMRI Study of SYN115 in Cocaine Dependent SubjectsCompletedNo Results AvailableCocaine DependenceDrug: SYN115|Drug: PLACEBOhttps://ClinicalTrials.gov/show/NCT00783276

* Görseller ve İçerik tekif hakkına sahip olabilir